Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Anticancer Research|September 1, 1992
Puromycin is a potent and specific inhibitor of tyrosine kinase activity in HL-60 cellsA N Davidoff, B V MendelowAnticancer Research|November 1, 1993
Puromycin-elicited c-myc mRNA superinduction precedes apoptosis in HL-60 leukaemic cellsA N Davidoff, B V MendelowBiotechniques|August 1, 1997
Identification of endonuclease activity in HIV-1 gp120 preparations produced using baculovirus expression systemsA N Davidoff, B V MendelowAnticancer Research|July 1, 1993
C-myc expression is down-regulated in mafosfamide-treated HL-60 cells undergoing apoptosisA N Davidoff, B V MendelowLeukemia Research|November 1, 1992
Unexpected cytokinetic effects induced by puromycin include a G2-arrest, a metaphase-mitotic-arrest, and apoptosisA N Davidoff, B V MendelowAnticancer Research|May 1, 1994
Protein synthesis inhibition is not a requisite for puromycin- and cycloheximide-induced c-myc mRNA superinductionA N Davidoff, B V MendelowExperimental Hematology|July 1, 1993
Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamideA N Davidoff, B V MendelowExperimental Hematology|March 1, 1993
Substituted purines elicit differential cytokinetic, molecular and phenotypic effects in HL-60 cellsA N Davidoff, B V MendelowInternational Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 4, 2001
Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?I Sanne, R A Smego, B V MendelowLeukemia Research|January 1, 1990
Application of flow cytochemistry to the evaluation of HL-60 differentiationC Wium, A N Davidoff, B V MendelowPageof 3